Prognostic biomarker MCP-4 triggers epithelial-mesenchymal transition via the p38 MAPK pathway in ovarian cancer

Prognostic biomarker MCP-4 triggers epithelial-mesenchymal transition via the p38 MAPK pathway in ovarian cancer

BackgroundMonocyte chemoattractant protein-4 (MCP-4/CCL13) is a proinflammatory factor that is overexpressed in various malignant tumors and may play an important role in tumor progression and metastasis. However, its role and mechanism of action in ovarian cancer remains unknown.MethodsImmunohistoc...

Full description

Bibliographic Details
Main Authors: Siting Li, Yuexin Hu, Ouxuan Liu, Xiao Li, Bei Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Oncology
Subjects:
p38 MAPK signaling pathway
apoptosis
EMT
ovarian cancer
MCP-4
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1034737/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1034737/full

Similar Items